Joseph Ziegler Net Worth

What's Joseph Ziegler's mailing address?

Joseph's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431.

Insiders trading at TherapeuticsMD

Over the last 13 years, insiders at TherapeuticsMD have traded over $60,334,483 worth of TherapeuticsMD stock and bought 3,746,989 units worth $33,644,571 . The most active insiders traders include Cooper C. Collins, Brian Bernick, and Robert G Finizio. On average, TherapeuticsMD executives and independent directors trade stock every 30 days with the average trade being worth of $233,918. The most recent stock trade was executed by Cooper C. Collins on 22 August 2024, trading 4,094 units of TXMD stock currently worth $7,083.

What does TherapeuticsMD do?

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD executives and stock owners

TherapeuticsMD executives and other stock owners filed with the SEC include:

• John Milligan,
  President, Secretary
• Brian Bernick,
  Co-Founder
• Robert Finizio,
  Chief Executive Officer and Director
• Robert G. Finizio,
  Co-Founder & Vice Chair
• Mitchell Krassan,
  Chief Strategy and Performance Officer
• John C. K. Milligan IV,
  Chief Exec. Officer of VitaCare Prescription Services
• Michael Donegan,
  Vice President - Finance
• Tommy Thompson,
  Independent Chairman of the Board
• Cooper Collins,
  Independent Director
• J. Martin Carroll,
  Independent Director
• Angus Russell,
  Independent Director
• Jules Musing,
  Independent Director
• Dr. Brian A. Bernick,
  Co-Founder & Chief Scientific Officer
• Nichol Ochsner,
  Vice President, Investor Relations
• Gail Naughton,
  Independent Director
• Karen Ling,
  Independent Director
• Paul Bisaro,
  Independent Director
• Bharat Warrier,
  Chief Manufacturing Officer
• Sebastian Mirkin,
  Chief Medical Officer
• Dawn Halkuff,
  Chief Commercial Officer
• Marlan Walker,
  General Counsel
• John Knighton,
  Chief Compliance Officer
• Adam Miller,
  Chief Information Officer
• James D'Arecca,
  Chief Financial Officer
• Julia M. Amadio,
  Chief Product Officer
• Mitchell L. Krassan,
  Exec. VP and Chief Strategy & Performance Officer
• Michael Donegan,
  Chief Accounting Officer & VP of Fin.
• James C. D'Arecca,
  Chief Financial Officer
• Hugh O'Dowd M.B.A.,
  Pres, CEO & Director
• Robert V Jr La Penta,
  Director
• Nicholas Segal,
  Director
• Daniel A Cartwright,
  Chief Financial Officer
• Capital Management Lp Rosen...,
  
• Jane F Barlow,
  Director
• Samuel A Greco,
  Director
• Randall S Stanicky,
  Director
• Edward Borkowski,
  EVP, Operations
• Hugh O'dowd,
  Chief Executive Officer
• Mark A Glickman,
  Co-Chief Executive Officer
• Joseph Ziegler,
  Principal Financial Officer